0% found this document useful (0 votes)
81 views3 pages

Endoscopic Management of Duodeno-Ileal Fistula Secondary To Diffuse B-Cell Lymphoma

Gejala klinis ikterus obstruktif
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
81 views3 pages

Endoscopic Management of Duodeno-Ileal Fistula Secondary To Diffuse B-Cell Lymphoma

Gejala klinis ikterus obstruktif
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 3

Journal of Surgical Case Reports, 2017;12, 1–3

doi: 10.1093/jscr/rjx249
Case Report

CASE REPORT

Endoscopic management of duodeno-ileal fistula

Downloaded from https://academic.oup.com/jscr/article-abstract/2017/12/rjx249/4781652 by guest on 21 February 2020


secondary to diffuse B-cell lymphoma
James A. Milburn1,*, John S. Leeds2, and Steven A. White1
1
Department of HPB and Transplant Surgery, Freeman Hospital, Newcastle-upon-Tyne NE7 7DN, UK and
2
Department Gastroenterology, Freeman Hospital, Newcastle-upon-Tyne NE7 7DN, UK
*Correspondence address. Department of HPB and Transplant Surgery, Freeman Hospital, Newcastle-upon-Tyne NE7 7DN, UK. Tel: +44-12-24-55-4169;
Fax: +44-12-24-55-1236; E-mail: [email protected]

Abstract
Lymphoma arising in the gastrointestinal tract is relatively common and can affect multiple sites. The development of a
gastrointestinal fistula secondary to lymphoma is very rare and has not previously been reported between the duodenum
and ileum. This is the first reported care where a fistula secondary to lymphoma has been treated by an endoscopic covered
duodenal stent occluding the defect rather than surgical intervention. This strategy permitted early commencement of cura-
tive intent chemotherapy which led to tumour shrinkage and fistula closure.

INTRODUCTION 8–10 watery stools per day which were noted to contain
recently ingested foodstuffs. Past medical history included
Primary gastrointestinal lymphoma (PGIL) accounts for 30–40% of
hypertension, diabetes, bronchiectasis and obesity. Four years
extra-nodal malignant lymphoma cases and up to 10–15% of all
previously he had undergone laparotomy for common bile duct
non-Hodgkin’s lymphoma (NHL) [1]. Temporal data series sug-
exploration and cholecystectomy through a supraduodenal
gest the incidence of PGIL is increasing in the Western world
approach. Prior endoscopic retrograde cholangiopancreatogra-
although the reasons are uncertain. Internal entero-entero fistu-
phy was unsuccessful due to multiple large calculi although no
lation between intestinal segments can be due to multiple aeti-
duodenal abnormalities were noted either before or after this
ologies although there are sparse reports of lymphoma as a
intervention.
primary cause. Experience with the endoscopic management of
Initial upper GI endoscopy failed to enter the duodenum due
upper gastrointestinal (GI) fistulas is limited as an operative
to residue within the stomach with the appearance and odour
intervention is often performed. We report the case of an 80-
of faeces noted. Abdominal computed tomography (CT) sug-
year-old man who presented with symptomssds attributable to a
gested a cavity with adherent ileum adjacent to the second part
duodeno-ileal fistula secondary to diffuse B-cell lymphoma lead-
of the duodenum (Fig. 1). A contrast study was then undertaken
ing to the first reported case of endoscopic management.
demonstrating rapid flow of contrast into the terminal ileum
and caecum originating from the duodenum (Fig. 2). Repeat
upper GI endoscopy demonstrated an abnormal fungating fistu-
CASE REPORT lous communication between the duodenum and terminal
An 80-year-old male presented to the emergency department ileum which permitted the full insertion of the endoscope (Figs
with worsening diarrhoea and faeculent vomiting on a back- 3 and 4). Biopsies were consistent with diffuse B-cell lymphoma
ground of significant weight loss and dyspepsia. He passed (DLBCL) in accordance with the WHO classification.

Received: September 22, 2017. Accepted: November 22, 2017


Published by Oxford University Press and JSCR Publishing Ltd. All rights reserved. © The Author(s) 2017.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/
licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
For commercial re-use, please contact [email protected]

1
2 | J.A. Milburn et al.

Downloaded from https://academic.oup.com/jscr/article-abstract/2017/12/rjx249/4781652 by guest on 21 February 2020


Figure 3: Endoscopic images of duodenum.

Figure 1: Computed tomography image of duodenal-ileal mass (arrow indicates


cavity).

Figure 4: Endoscopic image through duodenal fistula.

radiological and upper GI endoscopy showed sealing of the fis-


tula at 3 months. (Fig. 5) The patient was able to resume a full
oral diet when the stent was removed. Six months following
diagnosis the patient continues to do well with a good response
to chemotherapy with planned CT surveillance.

DISCUSSION
Figure 2: Oral contrast study showing transit of barium into the ileum from a
PGLI lymphoma can affect any segment of the GI tract with a
duodenal source through a cavity (arrow indicates cavity arising from
duodenum).
variety of pathological subtypes exhibiting a global variation.
The most frequent PGLI arise from proliferating peripheral B-
lymphocytes and over half lead to DLBCL [2]. In a Western
The patient was commenced on a combination of parenteral population approximately half of PGLI arise in the stomach,
nutrition with passage of a nasojejunal tube beyond the fistula with a quarter in the small intestine and 10% the colon, with
with cautious introduction of enteral feeding. He was assessed rare presentations in the oesophagus, liver or pancreas. Up to
for surgical intervention but due to his comorbidities this was 15% of patients will have multiple sites of involvement in the
considered very high risk. He therefore underwent insertion of GI tract [3].
a fully covered self expanding metal stent (60 × 20 mm2 duo- Haldane reported the first case of a malignant GI fistula due
denal stent, Tawoong Medical, South Korea) to cover the defect. to adenocarcinoma in 1862 while lymphoma was first impli-
He symptomatically improved and commenced com- cated as aetiology in 1946 [4, 5]. A 2005 review of the literature
bination chemotherapy (R-GCVP Rituximab, Gemciabine, concluded that <20 entero-entero fistulae secondary to lymph-
Cyclophosphamide, Vincristine and Prednisolone). Subsequent oma had been reported primarily treated surgically [6]. These
Endoscopic management of duodeno-ileal fistula secondary | 3

vomiting. However, surgery remains advocated by some groups


especially for intestinal (non-gastric) tumours reporting improved
outcomes with adjuvant chemotherapy rather than chemother-
apy alone [3]. Furthermore, indolent tumour including Mantle or
Follicular subtypes where chemotherapy is less effective may also
benefit from resection [1].
In this case, surgery would have required a pancreaticoduo-
denectomy with a right hemicolectomy conferring a high risk
of mortality and morbidity in this elderly patient. Surgery was
avoided by the use of a covered duodenal stent which simul-
taneously excluded the defect allowing restoration of enteral
nutrition and allowed early introduction of chemotherapy

Downloaded from https://academic.oup.com/jscr/article-abstract/2017/12/rjx249/4781652 by guest on 21 February 2020


agents avoiding delay to treatment in postoperative recovery.
The use of duodenal stents to treat fistulating conditions of the
GI tract including the duodenum has previously been reported
although often this is in palliative setting [10].
Our report has described the novel use of a duodenal stent
as bridging therapy to facilitate early introduction of chemo-
therapy in a complex patient. Advanced endoscopic techniques
can be a useful therapeutic modality in PGIL cases to avoid sur-
gery and improve outcomes.

Figure 5: Computed tomography image showing improvement in appearances


(stent removed).
CONFLICT OF INTEREST STATEMENT
None declared.
intra-abdominal internal lymphomatous fistulae are more
commonly jejuno-colic or gastro-colic [6, 7].
No previous cases of duodeno-ileal fistulae secondary to
PGLI have been reported in the literature suggesting this is the
REFERENCES
first reported case. Colo-enteric fistulae between duodenum 1. Cheung MC, Housri N, Ogilvie MP, Sola JE, Koniaris LG.
and colon often arise due to their anatomic proximity although Surgery does not adversely affect survival in primary
it is unclear why the ileum in this patient was in proximity to gastrointestinal lymphoma. J Surg Oncol 2009;100:59–64.
the second part of the duodenum. This would normally suggest 2. Boot H. Diagnosis and staging in gastrointestinal lymph-
fistulation through the mesocolon although given the previous oma. Best Pract Res Clin Gastroenterol 2010;24:3–12.
upper abdominal surgery the ileum could have migrated close 3. Nakamura S, Matsumoto T. Gastrointestinal lymphoma:
to the duodenum post operatively. recent advances in diagnosis and treatment. Digestion 2013;
It is difficult to ascertain whether the DLBCL originated in 87:182–8.
the duodenum or terminal ileum. The ileum is the commonest 4. Haldane DR. Case of cancer in the caecum accompanied
site of origin for small bowel GI lymphoma therefore this case with caeco-duodenal and caeco-colic fistulae. Edinburgh Med
is likely to represent a DLBCL originating in the ileum fistulat- J 1862;7:624–9.
ing into the duodenum [8]. Follicular and mantle cell lymph- 5. De Nadal H, Bonnin C. Fistula gastrocolica por reticulo-
oma of the duodenum but without fistulation have been sarcome. Med Clin (Barc) 1946;7:312–5.
reported although would be different histological subtype to 6. McMahon LE, Tessier DJ, Devine RM, McConnell EJ.
this case [9]. Lymphoma creating colojejunal fistula: report of a case and
Macroscopic subtypes of PGIL have been described within review of the literature. Dis Colon Rectum 2005;48:158–61.
the small bowel and in our case was likely an ulcerative variant 7. Laufer I, Joffe N, Stolberg H. Unusual causes of gastrocolic
as these are commonest among DLBCL and would predispose fistula. Gastrointest Radiol 1977;2:21–5.
to fistulation. 8. Wang GB, Xu GL, Luo GY, Shan HB, Li Y, Gao XY, et al.
The management of PGIL has evolved with chemotherapy, Primary intestinal non-Hodgkin’s lymphoma: a clinico-
radiotherapy and immunotherapy combinations the optimal pathologic analysis of 81 patients. World J Gastroenterol 2011;
treatment with surgery often restricted to the treatment of 17:4625–31.
complications including fistulae. 9. Moussaide G, Kazemi A, Mitre R, Mitre MC. Mantle cell
Upper GI surgery for PGIL can result in significant peri- lymphoma: a rare cause of a solitary duodenal mass. BMJ
operative complications leading to a high risk of morbidity and Case Rep 2014, doi:10.1136/bcr-2014-203823.
potential mortality [1]. Duodenal fistulas are particularly diffi- 10. Nagula S, Buscaglia JM, Bucobo JC. Too much to bear: endo-
cult to manage because of the risk of high output fluid loss and scopic palliation of a duodenal fistula. Gastrointest Endosc
sepsis while causing distressing symptoms including faeculent 2014;80:521–2.

You might also like